The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies.
Ontology highlight
ABSTRACT: Soft tissue sarcomas (STS) are a rare, complex, heterogeneous group of mesenchymal neoplasms with over 150 different histological subtypes. Treatments for this malignancy have been especially challenging due to the heterogeneity of the disease and the modest efficacy of conventional chemotherapy. The next frontier lies in discerning the molecular pathways in which these mesenchymal neoplasms arise, metastasize, and develop drug-resistance, thereby helping guide new therapeutic targets for the treatment of STS. This comprehensive review will discuss the current understanding of tumorigenesis of specific STS subtypes, including oncogenic pathway alterations involved in cell cycle regulation, angiogenesis, NOTCH signaling, and aberrant genetic rearrangements. It will then review current thera
SUBMITTER: Kim T
PROVIDER: S-EPMC10046114 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA